DUROTEP MT Adverse Event: Malignant neoplasm progression
DUROTEP MT Adverse Event: Malignant neoplasm progression is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: DUROTEP MT; Product category: Drug; Primary reaction: Malignant neoplasm progression.
| Primary drug | DUROTEP MT |
|---|---|
| Product category | Drug |
| Primary reaction | Malignant neoplasm progression |
| All reactions | Malignant neoplasm progression |
| Seriousness | Serious |
| Patient outcome | Fatal |
| Patient sex | Unknown |
| All drugs reported | DUROTEP MT |
| Reporter country | JP |
| Reporter type | 2 |
| Report date | 20140312 |
| Report ID | 10004226 |
$299/mo
Try FDATracker →